The gene KRAS is commonly mutated in lung cancer to encode a constitutively active and oncogenic protein that is well established to initiate and maintain lung tumorigenesis. However, the remaining wild-type KRAS protein, or the other family members HRAS and NRAS, can still be activated in the presence of oncogenic KRAS. Moreover, loss of any one of these three genes has been shown to increase the sensitivity of mice to the carcinogen urethane, which induces Kras mutation-positive early lung lesions. To determine the contribution of progressively disrupting Hras and Nras genes on urethane lung tumorigenesis, mice with different combinations of wild-type and null alleles of Hras and Nras were exposed with urethane and tumor burden was assess...
Mouse models have been an essential tool for cancer research for many decades, and have seen applica...
Oncogenic, activating mutations in KRAS initiate pancreatic cancer. There are, however, two other Ra...
Pulmonary adenoma susceptibility 1 (Pas1) is the major locus responsible for lung tumor susceptibili...
Ras oncogenes (Hras, Kras, and Nras) are important drivers of carcinogenesis. However, tumors with R...
Ras oncogenes (Hras, Kras, and Nras) are important drivers of carcinogenesis. However, tumors with R...
Kras is the most frequently mutated ras family member in lung carcinomas, whereas Hras mutations are...
Ras oncogenes (Hras, Kras and Nras) are important drivers of carcinogenesis. However, tumors with Ra...
<p>The RAS family is a group of small GTPases that can become constitutively activated by point muta...
Lung cancer remains the leading cause of cancer death in the United States. Despite an increased ass...
To examine the roles of endogenous K-ras 4A and K-ras 4B splice variants in tumorigenesis, murine lu...
Ki-ras and p53 genes are involved in human lung carcinogenesis; however, the role of these genes in ...
A locus for mouse pulmonary adenoma susceptibility, Pas-1, has been mapped on distal chromosome 6, w...
BackgroundThe RAS family of small GTPases is comprised of HRAS, NRAS, and KRAS. KRAS is invariably o...
<p>(<b>A</b>) Number of lesions counted per H&E-stained section of lung tissue from urethane-treated...
3These authors contributed equally to this work 4To whom correspondence should be addressed Differen...
Mouse models have been an essential tool for cancer research for many decades, and have seen applica...
Oncogenic, activating mutations in KRAS initiate pancreatic cancer. There are, however, two other Ra...
Pulmonary adenoma susceptibility 1 (Pas1) is the major locus responsible for lung tumor susceptibili...
Ras oncogenes (Hras, Kras, and Nras) are important drivers of carcinogenesis. However, tumors with R...
Ras oncogenes (Hras, Kras, and Nras) are important drivers of carcinogenesis. However, tumors with R...
Kras is the most frequently mutated ras family member in lung carcinomas, whereas Hras mutations are...
Ras oncogenes (Hras, Kras and Nras) are important drivers of carcinogenesis. However, tumors with Ra...
<p>The RAS family is a group of small GTPases that can become constitutively activated by point muta...
Lung cancer remains the leading cause of cancer death in the United States. Despite an increased ass...
To examine the roles of endogenous K-ras 4A and K-ras 4B splice variants in tumorigenesis, murine lu...
Ki-ras and p53 genes are involved in human lung carcinogenesis; however, the role of these genes in ...
A locus for mouse pulmonary adenoma susceptibility, Pas-1, has been mapped on distal chromosome 6, w...
BackgroundThe RAS family of small GTPases is comprised of HRAS, NRAS, and KRAS. KRAS is invariably o...
<p>(<b>A</b>) Number of lesions counted per H&E-stained section of lung tissue from urethane-treated...
3These authors contributed equally to this work 4To whom correspondence should be addressed Differen...
Mouse models have been an essential tool for cancer research for many decades, and have seen applica...
Oncogenic, activating mutations in KRAS initiate pancreatic cancer. There are, however, two other Ra...
Pulmonary adenoma susceptibility 1 (Pas1) is the major locus responsible for lung tumor susceptibili...